Nagi Bioscience has launched a Priority Access Program for its SydLab™ One platform, offering exclusive access to five top academic laboratories. The platform revolutionizes C. elegans experimentation by automating processes with microfluidics, robotics, optics, and AI. The participating labs will use SydLab™ One for high-throughput experiments in areas like oncology and neurodegenerative diseases. CEO Matteo Cornaglia is excited about the potential impact of the technology on scientific discoveries. The platform aims to address challenges in C. elegans research and advance automation in biological research. The program signifies a significant step forward in enhancing efficiency and precision in critical research fields.
Source link